---
schema_version: "secwatch.filing_event.v1"
accession: "0002046386-26-000022"
form_type: "8-K"
ticker: "MDLN"
cik: "0002046386"
company_name: "Medline Inc."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:58:34.494813+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medline Q1 sales up 10.7% to $7.4B; net income down 25.8%, adjusted EBITDA down 10.6%

## Summary
- Net income $239M (-25.8% YoY); Diluted EPS $0.16; Adjusted Diluted EPS $0.33.
- Organic sales growth 10.1%; total sales $7.4B driven by new customer signings and existing customer growth.
- Adjusted EBITDA $776M (-10.6% YoY) on higher tariffs, operating expenses, and IPO-related bonus.
- Raising full-year organic sales guidance to 8.5%-9.5% (prior 8%-9%); maintaining adjusted EBITDA outlook $3.5-$3.6B.
- Free Cash Flow $316M; net cash from ops $412M, capex for distribution centers and manufacturing.

## SEC filing metadata
- accession: 0002046386-26-000022
- form_type: 8-K
- ticker: MDLN
- cik: 0002046386
- company_name: Medline Inc.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2046386/000204638626000022/0002046386-26-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2046386/000204638626000022/mdln-20260506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002046386-26-000022
- JSON: https://secwatch.observer/filing/0002046386-26-000022.json
- Plain text: https://secwatch.observer/filing/0002046386-26-000022.txt

## Source-grounded claims
- claim_id: b297508d67d04dbe415ace8ef8152478d0bc4998
  claim: Medline Inc. reported the three months ended March 28, 2026 results: revenue $7.4 billion, net income $239 million, EPS $0.16. Guidance raised.
  evidence_excerpt: Net sales of $7.4 billion, an increase of 10.7% • Net income of $239 million, a decrease of 25.8%
  evidence_url: https://www.sec.gov/Archives/edgar/data/2046386/000204638626000022/0002046386-26-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.